Cart
sales@molnova.com
Docosapentaenoic acid 22n-3
CAS No. 24880-45-3
Docosapentaenoic acid 22n-3 ( —— )
Catalog No. M24134 CAS No. 24880-45-3
Docosapentaenoic acid 22n-3 is present in the cell membranes of all animals and is a component of phospholipids.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 132 | In Stock |
|
| 10MG | 197 | In Stock |
|
| 25MG | 329 | In Stock |
|
| 50MG | 491 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDocosapentaenoic acid 22n-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionDocosapentaenoic acid 22n-3 is present in the cell membranes of all animals and is a component of phospholipids.
-
DescriptionDocosapentaenoic acid 22n-3 is present in the cell membranes of all animals and is a component of phospholipids.
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number24880-45-3
-
Formula Weight330.5
-
Molecular FormulaC22H34O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sinclair HM, et al. Essential fatty acids in perspective. Hum Nutr Clin Nutr. 1984 Jul;38(4):245-60.
molnova catalog
related products
-
D(-)-2-Aminobutyric ...
D(-)-2-Aminobutyric acid is the substrate of D-amino acid oxidase.
-
L-Azetidine-2-carbox...
L-2-Azetidinecarboxylic acid is a toxic proline analogue produced by members of the Liliaceae and Agavaciae families.
-
Nα-Acetyl-L-lysine
N-Alpha-acetyllysine is a N-acetylated amino acid. It is a normal constituent of human urine with concentrations in normal samples too small to allow its routine detection; however it has been found at increased levels in the urine of a patient with aminoacylase I deficiency.
